Drug interactions
Clevidipine + Metformin-repaglinide
Severity: Minor
Clevidipine and Metformin-repaglinide: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Calcium channel blockers have been reported to cause modest hyperglycemia and may slightly reduce glycemic control. Clevidipine is short-acting and given intravenously, so any effect is likely minor.
What this interaction means in plain words
Clevidipine and Metformin-repaglinide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Clevidipine belongs to Cardiovascular; Metformin-repaglinide belongs to Endocrine.
Why it happens
Calcium channel blockade may modestly reduce insulin secretion; the evidence is limited.
What to do
Monitor blood glucose during clevidipine infusion in diabetic patients and treat hyperglycemia as needed.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Clevidipine and Metformin-repaglinide, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Metformin-repaglinide
Other interactions of Clevidipine
Frequently asked questions
Can I take Clevidipine with Metformin-repaglinide?
MediHelp rates the interaction as minor. Clevidipine and Metformin-repaglinide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Calcium channel blockers have been reported to cause modest hyperglycemia and may slightly reduce glycemic control. Clevidipine is short-acting and given intravenously, so any effect is likely minor.
How serious is the interaction between Clevidipine and Metformin-repaglinide?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose during clevidipine infusion in diabetic patients and treat hyperglycemia as needed.
What other medicines interact with Metformin-repaglinide?
MediHelp also lists interactions of Metformin-repaglinide with, for example, Gemfibrozil, Apalutamide, Clarithromycin. The full list is on the Metformin-repaglinide page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
